6
Journal of Chemical Research 00(0)
(d, J=7.6Hz, 1H), 6.96 (t, J=8.0Hz, 2H), 5.29 (s, 1H),
3.45 (s, 2H), 1.30 (s, 9H). 13C NMR (126MHz, CDCl3): δ
169.4, 163.0 (d, JC–F =247Hz), 137.9 (d, JC–F =8Hz), 130.3
(d, JC–F =8Hz), 124.8 (d, JC–F =3Hz), 116.2 (d, JC–F =21Hz),
114.0 (d, JC–F =20Hz), 51.4, 44.4, 28.7. 19F NMR (565MHz,
CDCl3): δ −112.68 (s, 1F).
N-(tert-butyl)-4-(trifluoromethyl)benzamide (1h): White
1
powder, m.p. 136–137°C (lit.19 136–137°C), H NMR
(500MHz, CDCl3): δ 7.81 (d, J=8.1Hz, 2H), 7.66 (d,
J=8.1Hz, 2H), 5.96 (s, 1H), 1.48 (s, 9H). 13C NMR
(126MHz, CDCl3): δ 165.6, 132.8 (q, JC–F =33Hz), 127.2,
125.5 (q, JC–F =3Hz), 123.7 (q, JC–F =273Hz), 52.0, 28.8.
19F NMR (565MHz, CDCl3): δ −62.89 (s, 3F).
Scheme 2. The mechanism of the Ritter reaction catalyzed by
Cu(OTf)2.
N-(tert-butyl)-2-(o-tolyl)acetamide (1i): White powder,
1
m.p. 108–109°C (lit.32 108–109°C), H NMR (500MHz,
CDCl3): δ 7.21–7.14 (m, 4H), 5.08 (s, 1H), 3.49 (s, 2H),
heating. The reaction of di-tert-butyl dicarbonate with solid 2.29 (s, 3H), 1.26 (s, 9H). 13C NMR (126MHz, CDCl3): δ
nitriles afforded the corresponding amides under solvent- 169.9, 137.1, 134.0, 130.7, 130.3, 127.6, 126.5, 51.1, 43.1,
free conditions.
28.6, 19.4.
N-(tert-butyl)-2-(2-fluorophenyl)acetamide (1j): White
Analytical data for amides 1a–s. N-(tert-butyl)benzamide powder, m.p. 102–103°C (lit.31 102–103°C), H NMR
(1a): White powder, m.p. 133–134°C (lit.27 133–134°C). (500MHz, CDCl3): δ 7.35–7.27 (m, 2H), 7.11–7.07 (m,
1H NMR (500MHz, CDCl3): δ 7.72 (d, J=7.5Hz, 2H), 2H), 5.37 (s, 1H), 3.51 (s, 2H), 1.33 (s, 9H). 13C NMR
7.47 (t, J=7.3Hz, 1H), 7.41 (t, J=7.5Hz, 2H), 5.93 (s, 1H), (126MHz, CDCl3): δ 169.0, 160.9 (d, JC–F =246Hz), 131.5
1.48 (s, 9H); 13C NMR (126MHz, CDCl3): δ 166.9, 136.0, (d, JC–F =4Hz), 129.0 (d, JC–F =8Hz), 124.4 (d, JC–F =4Hz),
1
131.0, 128.4, 126.7, 51.6, 28.9.
122.7 (d, JC–F =15Hz), 115.4 (d, JC–F =21Hz), 51.3, 38.0,
N-(tert-butyl)-2-methylbenzamide (1b): White powder, 28.6. 19F NMR (565MHz, CDCl3): δ −117.49 (s, 1F).
m.p. 77–78°C (lit.28 77–78°C). 1H NMR (500MHz,
N-(tert-butyl)-4-methoxybenzamide (1k): White pow-
CDCl3): δ 7.33–7.26 (m, 2H), 7.18 (dd, J=12.8, 7.1Hz, der, m.p. 118–119°C (lit.30 118–119°C), 1H NMR
2H), 5.59 (s, 1H), 2.43 (s, 3H), 1.47 (s, 9H); 13C NMR (500MHz, CDCl3): δ 7.68 (d, J=8.7Hz, 2H), 6.89 (d,
(126MHz, CDCl3): δ 169.6, 137.9, 135.4, 130.8, 129.3, J=8.7Hz, 2H), 5.86 (s, 1H), 3.83 (s, 3H), 1.46 (s, 9H). 13C
126.4, 125.6, 51.7, 28.9, 19.5.
NMR (126MHz, CDCl3): δ 166.4, 161.9, 128.4, 128.3,
N-(tert-butyl)-3-methylbenzamide (1c): White powder, 113.6, 55.4, 51.4, 28.9.
1
m.p. 111–112°C (lit.27 111–112°C), H NMR (500MHz,
N-(tert-butyl)-2-phenylacetamide (1l): White powder,
CDCl3): δ 7.56–7.46 (m, 2H), 7.30–7.26 (m, 2H), 5.93 (s, m.p. 112–113°C (lit.16 112–113°C), H NMR (500 MHz,
1H), 2.38 (s, 3H), 1.47 (s, 9H); 13C NMR (126MHz, CDCl3): δ 7.31 (t, J=7.4 Hz, 2H), 7.23 (dd, J=13.3, 6.3Hz,
CDCl3): δ 167.1, 138.3, 136.0, 131.7, 128.3, 127.5, 123.6, 3H), 5.19 (s, 1H), 3.45 (s, 2H), 1.26 (s, 9H). 13C NMR
1
51.5, 28.9, 21.3.
(126MHz, CDCl3): δ 170.2, 135.5, 129.2, 128.9, 127.1,
N-(tert-butyl)-4-methylbenzamide (1d): White powder, 51.2, 44.9, 28.7.
1
m.p. 112–113°C (lit.27 112–113°C), H NMR (500MHz,
N-(tert-butyl)-2-(4-nitrophenyl)acetamide (1m): White
CDCl3): δ 7.61 (d, J=8.1Hz, 2H), 7.20 (d, J=8.0Hz, 2H), powder, m.p. 162–163°C (lit.6 162–163°C), H NMR
5.90 (s, 1H), 2.38 (s, 3H), 1.47 (s, 9H); 13C NMR (126MHz, (500MHz, CDCl3): δ 8.18 (d, J=8.6Hz, 2H), 7.44 (d,
CDCl3): δ 166.8, 141.3, 133.1, 129.1, 126.7, 51.5, 28.9, 21.3. J=8.5Hz, 2H), 5.33 (s, 1H), 3.54 (s, 2H), 1.33 (s, 9H); 13C
2-(4-bromophenyl)-N-(tert-butyl)acetamide (1e): White NMR (126MHz, CDCl3): δ 168.2, 147.1, 142.9, 130.0,
1
powder, m.p. 151–152°C (lit.29 151–152°C), H NMR 123.8, 51.7, 44.2, 28.7.
1
(500MHz, CDCl3): δ 7.45 (d, J=8.3Hz, 2H), 7.12 (d,
N-(tert-butyl)cyclopentanecarboxamide (1n): White
1
J=8.2Hz, 2H), 5.23 (s, 1H), 3.41 (s, 2H), 1.29 (s, 9H); 13C powder, m.p. 98–100°C, H NMR (500MHz, CDCl3): δ
NMR (126MHz, CDCl3): δ 169.5, 134.4, 131.9, 130.9, 5.23 (s, 1H), 2.46–2.35 (m, 1H), 1.84–1.77 (m, 2H), 1.76–
121.1, 51.4, 44.1, 28.7.
N-(tert-butyl)-3-fluorobenzamide (1f): White powder, (126MHz, CDCl3): δ 175.6, 50.8, 46.5, 30.4, 28.9, 25.9.
1.70 (m, 4H), 1.57–1.53 (m, 2H), 1.34 (s, 9H); 13C NMR
1
m.p. 108–109°C (lit.30 108–109°C), H NMR (500MHz,
N-(tert-butyl)cyclopropanecarboxamide (1o): White
CDCl3): δ 7.47–7.35 (m, 3H), 7.16–7.14 (m, 1H), 5.89 (s, powder, m.p. 123–125°C (lit.33 123–125°C), H NMR
1H), 1.47 (s, 9H); 13C NMR (126MHz, CDCl3): δ 165.5, (500MHz, CDCl3): δ 5.44 (s, 1H), 1.35 (s, 9H), 1.26–1.21
162.8 (d, JC–F =248Hz), 138.3 (d, JC–F =6Hz), 130.1 (d, (m, 1H), 0.92–0.86 (m, 2H), 0.68–0.61 (m, 2H); 13C NMR
JC–F =8Hz), 122.1 (d, JC–F =4Hz), 118.1 (d, JC–F =21Hz), (126MHz, CDCl3): δ 172.6, 51.1, 28.9, 15.3, 6.6.
1
114.2 (d, JC–F =23Hz), 51.8, 28.8. 19F NMR (565MHz,
CDCl3): δ −112.04 (s, 1F).
N-(tert-butyl)cyclohexanecarboxamide (1p): White
1
powder, m.p. 156–158°C (lit.14 156–158°C), H NMR
N-(tert-butyl)-2-(3-fluorophenyl)acetamide (1g): White (500MHz, CDCl3): δ 5.24 (s, 1H), 1.92 (dd, J=19.1,
1
powder, m.p. 106–108°C (lit.31 106–108°C), H NMR 7.4Hz, 1H), 1.83–1.70 (m, 4H), 1.63 (d, J=7.6Hz, 1H),
(500MHz, CDCl3): δ 7.29 (dd, J=14.3, 7.9Hz, 1H), 7.02 1.45–1.34 (m, 2H), 1.31 (s, 9H), 1.26–1.16 (m, 3H); 13C